Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study.
Study Details
Study Description
Brief Summary
This trial is a multicenter prospective cohort study to explore timing of colorectal cancer surgery after COVID-19 infection so that can assist clinicians and patients. Currently, there is less evidence on perioperative outcomes after COVID-19 vaccination and the omicron variant. Therefore, it is necessary to update previously published consensus which recommends that patients should avoid elective surgery within 7 weeks of COVID-19 infection remain, unless the benefits of doing so exceed the risk of waiting. Aiming at the above problems, we plan to carry out a multicenter prospective cohort study to develop perioperative management according patients' different conditions.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
More than 7 weeks Timing of colorectal cancer surgery is more than 7 weeks after confirmed COVID-19 infection by COVID-19 nucleic acid test. |
Procedure: Timing of colorectal cancer surgery
The timing of colorectal cancer surgery is different according patients' different conditions which is difined as more than 7 weeks or less than 7 weeks.
|
Less than 7 weeks Timing of colorectal cancer surgery is less than 7 weeks after confirmed COVID-19 infection by COVID-19 nucleic acid test. |
Procedure: Timing of colorectal cancer surgery
The timing of colorectal cancer surgery is different according patients' different conditions which is difined as more than 7 weeks or less than 7 weeks.
|
Outcome Measures
Primary Outcome Measures
- Incidence of surgical complications [30 days after surgery]
Complications including: intraperitoneal hemorrhage, anastomotic leak, anastomotic bleeding, abdominal infection, pulmonary infection, chylous fistula, intestinal obstruction, et al.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
undergoing colorectal cancer surgery
-
infected with COVID-19 but nucleic acid test result is negative
-
the patients compliance is good
-
signed the consents voluntarily
Exclusion Criteria:
-
undergoing emergency surgery(intestinal obstruction, intestinal perforation, intestinal hemorrhage, et al.)
-
The patients' situations which judged by situations is not suitable to participate in the clinical trial
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Changhai Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- WeiZhang